The sun is finally shining in London and as Londoners head to the park, over 220 speakers and delegates from 11 countries will be heading to the UK Breast Cancer Research Symposium to discuss the latest progress in breast cancer research.
The symposium will be focussing on how to turn lab research into real progress for patients, what’s known as translational research. This is often a step that throws up unexpected challenges, so when, last year, some of the most distinguished scientists and clinicians working in the UK told us that organising a conference on breast cancer research would help them to speed up progress, we listened carefully and took action - the first UK Breast Cancer Research Symposium was born.
With this new symposium, we’re getting the brightest minds in breast cancer together under one roof, where they’ll share what they know, battle out differences of opinion, and scan the horizon for promising new research directions.
World-renowned breast cancer experts will be presenting on disciplines as diverse as immunology, genetics and 3D tissue modelling. From Professor Sir Mike Stratton’s first plenary talk to Dr Dennis Slamon’s concluding remarks, the programme is filled with cutting-edge talks and insightful debate on how to tackle the most difficult challenges in breast cancer research today.
Importantly, the symposium will also give voice to the patient perspective. Women and men living with the disease are at the heart of our work and we are pleased that a number of patients will be attending the conference to shape discussions and debate around the critical issues facing people with breast cancer right now.
Follow our updates
To keep up with the action as it unfolds be sure to look out for our tweets from the conference using #UKBCRS2016. We will also be reporting on the symposium highlights early next week with blogs and videos from both days of the symposium.